Open-ended hypothesis discovery at a scale human teams cannot reach.
Cambridge, UK
Scroll to explore
The Problem
The highest-stakes decisions in medicine are made blind
Drug development fails not from lack of data, but from poor hypothesis selection.
The combinatorial space of targets, biomarkers, and patient strategies is too vast to explore manually. The most promising hypotheses stay invisible.
Existing tools answer questions. They do not decide which questions matter.
Our Platform
Open-ended hypothesis discovery
Nethaira deploys networks of AI scientists that don't wait for instructions.
They autonomously explore multimodal biological data, continuously generating, testing, and refining hypotheses to uncover the targets and biomarkers that guide precision trial design.
Not just the ones you thought to ask about. At a scale no human team can match.
From Chaos to Clarity
Data
Network
Hunt
Decide
Spatial Biology Focus
7 cell phenotypes
MERFISH · 10um res
Drag to pan
Shift+drag rotate
Team
Built by scientists, for scientists
We combine deep scientific expertise with world-class engineering.
We bring together cutting-edge machine learning research, biotech founding experience, and a multidisciplinary background spanning translational medicine, spatial omics, clinical strategy, and healthcare ventures.
Advised by leading Cambridge labs.
Contact
Partner with us
We are selecting strategic partners for early access. Translational teams working on spatial biology, patient stratification, or biomarker discovery.